Theator is a surgical intelligence platform that combines artificial intelligence and computer vision to improve surgeon performance.
Theator has raised $24.0M in total funding. The most recent round was Series A. The last funding was announced in April 2022.
Theator's investors include Insight Venture Management, LLC., NFX, Mayo Clinic, StageOne Ventures, Blumberg Capital.
Theator is headquartered in Palo Alto, United States.
Theator is a surgical intelligence platform that combines artificial intelligence and computer vision to improve surgeon performance.
Theator is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Theator — Funding & Investors." VCBacked, April 26, 2022, https://www.vcbacked.co/company/theator. Accessed September 29, 2026.
VCBacked. (2022). Theator — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/theator
{{cite web |title=Theator — Funding & Investors |url=https://www.vcbacked.co/company/theator |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated